Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting

Authors
Publication date
Publisher
Dove Medical Press
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.2147%2Fjaa.s29811
      Last time updated on 01/04/2019